| Literature DB >> 27684100 |
Varahram Shahryari1, Hannah Nip1, Sharanjot Saini1, Altaf A Dar2, Soichiro Yamamura1, Yozo Mitsui1, Melissa Colden1, Nathan Bucay1, Laura Z Tabatabai1, Kirsten Greene1, Guoren Deng1, Yuichiro Tanaka1, Rajvir Dahiya1, Shahana Majid3.
Abstract
To study the multifaceted biology of prostate cancer, pre-clinical in vivo models offer a range of options to uncover critical biological information about this disease. The human orthotopic prostate cancer xenograft mouse model provides a useful alternative approach for understanding the specific interactions between genetically and molecularly altered tumor cells, their organ microenvironment, and for evaluation of efficacy of therapeutic regimens. This is a well characterized model designed to study the molecular events of primary tumor development and it recapitulates the early events in the metastatic cascade prior to embolism and entry of tumor cells into the circulation. Thus it allows elucidation of molecular mechanisms underlying the initial phase of metastatic disease. In addition, this model can annotate drug targets of clinical relevance and is a valuable tool to study prostate cancer progression. In this manuscript we describe a detailed procedure to establish a human orthotopic prostate cancer xenograft mouse model.Entities:
Year: 2016 PMID: 27684100 PMCID: PMC5091966 DOI: 10.3791/54125
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355